why is moderna stock dropping so much

The 56 analysts offering price forecasts for Moderna have a median target of 19804 with a high estimate of 46300 and a low estimate of 6000. Moderna stock fell as much as 13 on Monday to a 10-month low of less than 140 pushing shares down more than 30 over the past month amid a sell-off.


Moderna Mrna Us Covid 19 Coronavirus Vaccine Production Bloomberg

On average they anticipate.

. MRNA declined by about 20 over the last week five trading days considerably underperforming the. Moderna now has a market cap of more than 185 billion with the vaccine stock soaring more than 340 so far this year. Yet Pfizers shares are still falling -- but nearly half as much as BioNTech and Moderna stocks this morning.

MRNA were dropping 152 this week as of market close on Thursday based on data from SP Global Market Intelligence. There is a broad sell-off in the market and SP 500 is down. Their MRNA share price forecasts range from 10100 to 30400.

SOPA ImagesLightRocket via Getty Images. Investors seem to be increasingly pessimistic about future demand for Modernas COVID-19 vaccine. 12 Wall Street analysts have issued 1-year price objectives for Modernas shares.

Shares of Moderna are down by 7 today as higher Treasury yields put significant pressure on high-growth stocks. That makes Moderna bigger than several. There is a broad sell-off in the market.

Shares of Moderna NASDAQ.


Stock Market Today Dow Rose As Moderna Slumped Again Barron S


Modnera Mrna Stock Down 50 This Year Bloomberg


Biotech Stocks Are Down And Out Can These 2022 Trends Save Them Investor S Business Daily


Buy Moderna Stock It S More Than A One Hit Wonder Barron S


Merck Covid 19 Pill Success Slams Moderna Shares Shakes Up Healthcare Sector Reuters


Moderna Stock Will Continue To Fall Nasdaq Mrna Seeking Alpha


Why Moderna Stock Is Down 25 In Recent Weeks


Moderna Reaped More Than 12 Billion In Profits From Covid Vaccine Sales Last Year The Boston Globe


Pfizer And Moderna Raise Eu Covid Vaccine Prices Financial Times


Down 50 From Its Highs Moderna Stock Looks Like Good Value


Moderna Stock A Great Diversification Into Large Cap Nasdaq Mrna Seeking Alpha


Why Moderna Stock Tripped And Fell On Tuesday The Motley Fool


Moderna Stock Crumbled Investors Are Questioning Its Spectacular Surge Barron S


Top 20 Biopharmaceutical Companies Hold Their Spot Despite Market Cap Drop In Q1 2022 Pharmaceutical Technology


Why Are Moderna Executives Selling Stock While Developing A Coronavirus Vaccine Npr


The Story Of Mrna From A Loose Idea To A Tool That May Help Curb Covid


Where Will Moderna Be In 1 Year The Motley Fool


Biotech Stocks Are Down And Out Can These 2022 Trends Save Them Investor S Business Daily


Federal Lawmakers Invest Big In Covid 19 Vaccine Treatment Companies

Iklan Atas Artikel

Iklan Tengah Artikel 1

Iklan Tengah Artikel 2

Iklan Bawah Artikel